Coenzyme Q(10) (CoQ(10)) deficiency has been observed in apparently healthy
subjects as well as in patients with congestive heart failure, angina pect
oris, coronary artery disease, cardiomyopathy, hypertension, mitral valve p
rolapse and after coronary revascularization. CoQ(10) bolsters the synthesi
s of ATP and inhibits free radical damage, hence is useful in preventing ce
llular damage during ischaemia-reperfusion injury. The clinical benefits ar
e mainly due to its ability to improve energy production, antioxidant activ
ity, and membrane stabilizing properties. Several small scale studies indic
ate that coenzyme Q could be useful in patients with congestive heart failu
re, angina pectoris, cardiomyopathy, coronary artery disease, acute myocard
ial infarction and in the preservation of myocardium. CoQ(10) may also decr
ease lipoprotein (a) and plasma insulin. CoQ(10) is normally present in the
low-density lipoprotein cholesterol fraction and inhibits its oxidation in
dicating that it can inhibit atherosclerosis. It can also regenerate vitami
n E. CoQ(10) is known for producing minor gastrointestinal discomfort and e
levation in SGOT and LDH when used.